These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23392532)

  • 1. Decision-making in polydrug amphetamine-type stimulant users: an fMRI study.
    Koester P; Volz KG; Tittgemeyer M; Wagner D; Becker B; Gouzoulis-Mayfrank E; Daumann J
    Neuropsychopharmacology; 2013 Jul; 38(8):1377-86. PubMed ID: 23392532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human ecstasy (MDMA) polydrug users have altered brain activation during semantic processing.
    Watkins TJ; Raj V; Lee J; Dietrich MS; Cao A; Blackford JU; Salomon RM; Park S; Benningfield MM; Di Iorio CR; Cowan RL
    Psychopharmacology (Berl); 2013 May; 227(1):41-54. PubMed ID: 23241648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A voxel-based morphometry study of young occasional users of amphetamine-type stimulants and cocaine.
    Mackey S; Stewart JL; Connolly CG; Tapert SF; Paulus MP
    Drug Alcohol Depend; 2014 Feb; 135():104-11. PubMed ID: 24342420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurocognitive decision-making processes of casual methamphetamine users.
    Droutman V; Xue F; Barkley-Levenson E; Lam HY; Bechara A; Smith B; Lu ZL; Xue G; Miller LC; Read SJ
    Neuroimage Clin; 2019; 21():101643. PubMed ID: 30612937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reward-related decision-making deficits and elevated impulsivity among MDMA and other drug users.
    Hanson KL; Luciana M; Sullwold K
    Drug Alcohol Depend; 2008 Jul; 96(1-2):99-110. PubMed ID: 18384979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuated Neural Processing of Risk in Young Adults at Risk for Stimulant Dependence.
    Reske M; Stewart JL; Flagan TM; Paulus MP
    PLoS One; 2015; 10(6):e0127010. PubMed ID: 26076493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated impulsivity and impaired decision-making in abstinent Ecstasy (MDMA) users compared to polydrug and drug-naïve controls.
    Morgan MJ; Impallomeni LC; Pirona A; Rogers RD
    Neuropsychopharmacology; 2006 Jul; 31(7):1562-73. PubMed ID: 16292322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortical thinning in amphetamine-type stimulant users.
    Koester P; Tittgemeyer M; Wagner D; Becker B; Gouzoulis-Mayfrank E; Daumann J
    Neuroscience; 2012 Sep; 221():182-92. PubMed ID: 22750208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced behavioral and neural activation in stimulant users to different error rates during decision making.
    Paulus MP; Lovero KL; Wittmann M; Leland DS
    Biol Psychiatry; 2008 Jun; 63(11):1054-60. PubMed ID: 17949691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Young adults at risk for stimulant dependence show reward dysfunction during reinforcement-based decision making.
    Stewart JL; Flagan TM; May AC; Reske M; Simmons AN; Paulus MP
    Biol Psychiatry; 2013 Feb; 73(3):235-41. PubMed ID: 23021534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decision-making in chronic ecstasy users: a systematic review.
    Betzler F; Viohl L; Romanczuk-Seiferth N
    Eur J Neurosci; 2017 Jan; 45(1):34-44. PubMed ID: 27859780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blunted Frontostriatal Blood Oxygen Level-Dependent Signals Predict Stimulant and Marijuana Use.
    Blair MA; Stewart JL; May AC; Reske M; Tapert SF; Paulus MP
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2018 Nov; 3(11):947-958. PubMed ID: 29681519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insular and cingulate attenuation during decision making is associated with future transition to stimulant use disorder.
    Stewart JL; Butt M; May AC; Tapert SF; Paulus MP
    Addiction; 2017 Sep; 112(9):1567-1577. PubMed ID: 28387975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neural correlates of working memory in pure and polyvalent ecstasy (MDMA) users.
    Daumann J; Schnitker R; Weidemann J; Schnell K; Thron A; Gouzoulis-Mayfrank E
    Neuroreport; 2003 Oct; 14(15):1983-7. PubMed ID: 14561934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulant Treatment Trajectories Are Associated With Neural Reward Processing in Attention-Deficit/Hyperactivity Disorder.
    Schweren LJS; Groenman A; von Rhein D; Weeda W; Faraone SF; Luman M; van Ewijk H; Heslenfeld DJ; Franke B; Buitelaar JK; Oosterlaan J; Hoekstra PJ; Hartman CA
    J Clin Psychiatry; 2017 Jul; 78(7):e790-e796. PubMed ID: 28640989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: evidence from an 18-month longitudinal functional magnetic resonance imaging study.
    Daumann J; Fischermann T; Heekeren K; Thron A; Gouzoulis-Mayfrank E
    Biol Psychiatry; 2004 Sep; 56(5):349-55. PubMed ID: 15336517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrete memory impairments in largely pure chronic users of MDMA.
    Wunderli MD; Vonmoos M; Fürst M; Schädelin K; Kraemer T; Baumgartner MR; Seifritz E; Quednow BB
    Eur Neuropsychopharmacol; 2017 Oct; 27(10):987-999. PubMed ID: 28866005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opposing effects of acute and chronic d-amphetamine on decision-making in rats.
    Wong SA; Thapa R; Badenhorst CA; Briggs AR; Sawada JA; Gruber AJ
    Neuroscience; 2017 Mar; 345():218-228. PubMed ID: 27113327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated impulsivity and impaired decision-making cognition in heavy users of MDMA ("Ecstasy").
    Quednow BB; Kühn KU; Hoppe C; Westheide J; Maier W; Daum I; Wagner M
    Psychopharmacology (Berl); 2007 Jan; 189(4):517-30. PubMed ID: 16425060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychomotor Tremor and Proprioceptive Control Problems in Current and Former Stimulant Drug Users: An Accelerometer Study of Heavy Users of Amphetamine, MDMA, and Other Recreational Stimulants.
    Downey LA; Tysse B; Ford TC; Samuels AC; Wilson RP; Parrott AC
    J Clin Pharmacol; 2017 Oct; 57(10):1330-1337. PubMed ID: 28425095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.